首页 > 最新文献

Danish medical bulletin最新文献

英文 中文
High maternal HbA1c is associated with overweight in neonates. 母亲HbA1c高与新生儿超重有关。
Pub Date : 2011-09-01
Maria Rudkjær Mikkelsen, Sigrid Bruun Nielsen, Edna Stage, Elisabeth R Mathiesen, Peter Damm

Introduction: The aims of this study were to determine the prevalence of women with gestational diabetes mellitus (GDM) not obtaining HbA1c within the normal range (≤ 5.6%) before delivery and to examine whether elevated HbA1c values are associated with an increased risk of large for gestational age (LGA) infants.

Material and methods: A population of 148 women with singleton pregnancies who had been diagnosed with GDM < 34 weeks, and who had a minimum of two HbA1c tests with a ≥ 3 week interval. They were divided into those obtaining a HbA1c ≤ 5.6%, and those who did not before delivery and further stratified according to baseline HbA1c ≤ or > 5.6%. The primary outcome was LGA infants.

Results: A total of 51 (34%) women did not obtain a HbA1c ≤ 5.6% before delivery. The median HbA1c before delivery was 5.9% versus 5.3% in the two groups. At baseline, body mass index and HbA1c were higher in the women not obtaining the goal (30.9 versus 27.8 kg/m², 5.9% versus 5.1%, both p < 0.01). Women with an elevated HbA1c before delivery had a higher prevalence of LGA infants (adjusted odds ratio (OR) 3.1 (95% confidence interval (CI) 1.3-7.6) and neonatal hypoglycaemia (adjusted OR 6.2 (95% CI 1.3-29.0). Other pregnancy outcomes were similar in the two groups. Stratification according to baseline HbA1c did not seem to change the result.

Conclusion: Women with GDM not obtaining HbA1c within the normal range before delivery had a threefold increased risk of having an LGA infant and a sixfold increased risk of neonatal hypoglycaemia.

Funding: not relevant.

Trial registration: not relevant.

本研究的目的是确定妊娠期糖尿病(GDM)妇女在分娩前HbA1c未达到正常范围(≤5.6%)的患病率,并检查HbA1c升高是否与大胎龄儿(LGA)的风险增加有关。材料和方法:148名被诊断为GDM < 34周的单胎妊娠妇女,至少有两次HbA1c检测,间隔≥3周。将患者分为HbA1c≤5.6%组和分娩前HbA1c≤5.6%组,根据基线HbA1c≤或> 5.6%进一步分层。主要结局为LGA婴儿。结果:共有51名(34%)女性在分娩前HbA1c未达到≤5.6%。分娩前HbA1c中位数为5.9%,而两组为5.3%。基线时,未达到目标的女性体重指数和糖化血红蛋白更高(30.9 vs 27.8 kg/m²,5.9% vs 5.1%, p < 0.01)。分娩前HbA1c升高的妇女有更高的LGA婴儿患病率(校正优势比(OR) 3.1(95%置信区间(CI) 1.3-7.6)和新生儿低血糖(校正优势比(OR) 6.2 (95% CI 1.3-29.0)。两组的其他妊娠结局相似。根据基线HbA1c分层似乎没有改变结果。结论:分娩前HbA1c未在正常范围内的GDM妇女生下LGA婴儿的风险增加了3倍,新生儿低血糖的风险增加了6倍。资金:不相关。试验注册:不相关。
{"title":"High maternal HbA1c is associated with overweight in neonates.","authors":"Maria Rudkjær Mikkelsen,&nbsp;Sigrid Bruun Nielsen,&nbsp;Edna Stage,&nbsp;Elisabeth R Mathiesen,&nbsp;Peter Damm","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The aims of this study were to determine the prevalence of women with gestational diabetes mellitus (GDM) not obtaining HbA1c within the normal range (≤ 5.6%) before delivery and to examine whether elevated HbA1c values are associated with an increased risk of large for gestational age (LGA) infants.</p><p><strong>Material and methods: </strong>A population of 148 women with singleton pregnancies who had been diagnosed with GDM < 34 weeks, and who had a minimum of two HbA1c tests with a ≥ 3 week interval. They were divided into those obtaining a HbA1c ≤ 5.6%, and those who did not before delivery and further stratified according to baseline HbA1c ≤ or > 5.6%. The primary outcome was LGA infants.</p><p><strong>Results: </strong>A total of 51 (34%) women did not obtain a HbA1c ≤ 5.6% before delivery. The median HbA1c before delivery was 5.9% versus 5.3% in the two groups. At baseline, body mass index and HbA1c were higher in the women not obtaining the goal (30.9 versus 27.8 kg/m², 5.9% versus 5.1%, both p < 0.01). Women with an elevated HbA1c before delivery had a higher prevalence of LGA infants (adjusted odds ratio (OR) 3.1 (95% confidence interval (CI) 1.3-7.6) and neonatal hypoglycaemia (adjusted OR 6.2 (95% CI 1.3-29.0). Other pregnancy outcomes were similar in the two groups. Stratification according to baseline HbA1c did not seem to change the result.</p><p><strong>Conclusion: </strong>Women with GDM not obtaining HbA1c within the normal range before delivery had a threefold increased risk of having an LGA infant and a sixfold increased risk of neonatal hypoglycaemia.</p><p><strong>Funding: </strong>not relevant.</p><p><strong>Trial registration: </strong>not relevant.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 9","pages":"A4309"},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29975352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence based evaluation of immuno-coagulatory interventions in critical care. 重症监护中免疫凝固干预的循证评价。
Pub Date : 2011-09-01
Arash Afshari
<p><strong>Unlabelled: </strong>Cochrane systematic reviews with meta-analyses of randomised trials provide guidance for clinical practice and health-care decision-making. In case of disagreements between research evidence and clinical practice, high quality systematic reviews can facilitate implementation or deimplementation of medical interventions into clinical practice. This applies especially to treatment of critically ill patients where interventions are most often costly and the clinical conditions are associated with high mortality.</p><p><strong>Objectives: </strong>To assess the potential benefits or harms of 1) antithrombin III (AT III) for critically ill patients; 2) inhaled nitric oxide (INO) for acute respiratory distress syndrome (ARDS) and acute lung injury (ALI); 3) aerosolized prostacyclin for ARDS and ALI; 4) thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion.</p><p><strong>Methods: </strong>We performed four systematic reviews of relevant randomised clinical trials. To quantify the estimated effect of various interventions, we conducted meta-analyses, where appropriate, to determine intervention effects using the Cochrane Collaboration methodology, trial sequential analyses (TSA), the GRADE, and the PRISMA-guidelines when conducting our systematic reviews. All reviews were performed according to published protocols following the recommendations of the Cochrane Handbook for systematic reviews of interventions. We performed multiple subgroup and sensitivity analyses with regard to methodological quality and various clinical outcomes. Trials were identified through Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE Science Citation Index-Expanded, The Chinese Biomedical Database and LILACS. We included all randomized clinical trials. We hand-searched reference lists, reviews, and contacted authors and experts for additional trials. We searched ClinicalTrials.gov, Centre Watch Clinical Trials Listing Service and ControlledTrials.com for missed, unreported, or ongoing trials. We screened bibliographies of relevant articles and conference proceedings and wrote to trialists and pharmaceutical companies producing the drugs in question.</p><p><strong>Results: </strong>Four systematic reviews included a total of 44 trials with 5,551 patients. Only 15 of the trials were classified as trials with low risk of bias (high methodological quality) regarding generation of the allocation sequence, allocation concealment, blinding, follow-up and other types of bias. 1) Compared with placebo or no intervention, AT III did not significantly affect overall mortality (relative risk (RR) 0.96, 95% confidence interval (CI) 0.89 to 1.03). No subgroup analyses on risk of bias, populations of patients, or with and without adjuvant heparin yielded significant results. AT III significantly increased the risk of bleeding events (RR 1.52, 95% CI 1.30 to 1
未标记:Cochrane随机试验荟萃分析系统评价为临床实践和医疗保健决策提供指导。在研究证据和临床实践之间存在分歧的情况下,高质量的系统评价可以促进在临床实践中实施或取消医疗干预措施。这尤其适用于治疗危重病人,在这种情况下,干预措施往往费用高昂,而且临床状况与高死亡率有关。目的:评价1)抗凝血酶III (AT III)对危重患者的潜在利与弊;2)吸入性一氧化氮(INO)治疗急性呼吸窘迫综合征(ARDS)和急性肺损伤(ALI);3)雾化前列环素治疗ARDS和ALI;4)血栓造影(TEG)或血栓弹性测量(ROTEM)监测大量输血患者的血液治疗与常规护理。方法:我们对相关随机临床试验进行了四项系统评价。为了量化各种干预措施的估计效果,在适当的情况下,我们进行了荟萃分析,在进行系统评价时使用Cochrane协作方法、试验序列分析(TSA)、GRADE和prisma指南来确定干预效果。所有的评价都是按照Cochrane手册对干预措施系统评价的建议,按照已发表的方案进行的。我们对方法学质量和各种临床结果进行了多亚组和敏感性分析。试验通过Cochrane中央对照试验注册中心(Central)、MEDLINE、EMBASE科学引文索引扩展、中国生物医学数据库和LILACS进行鉴定。我们纳入了所有随机临床试验。我们手工检索了参考文献列表、综述,并联系了作者和专家进行额外的试验。我们检索了ClinicalTrials.gov、center Watch临床试验列表服务和ControlledTrials.com,查找错过的、未报告的或正在进行的试验。我们筛选了相关文章和会议记录的参考书目,并写信给试验人员和生产有关药物的制药公司。结果:4项系统综述共纳入44项试验,共纳入5551例患者。只有15项试验在分配序列的产生、分配隐藏、盲法、随访和其他类型的偏倚方面被归类为低偏倚风险(方法学质量高)的试验。1)与安慰剂或无干预相比,AT III对总死亡率无显著影响(相对危险度(RR) 0.96, 95%可信区间(CI) 0.89 ~ 1.03)。没有关于偏倚风险、患者群体或使用和不使用辅助肝素的亚组分析产生显著结果。AT III显著增加出血事件的风险(RR 1.52, 95% CI 1.30 ~ 1.78)。2) INO对总死亡率的影响无统计学意义(RR 1.06, 95% CI 0.93 ~ 1.22),在几个亚组和敏感性分析中均无统计学意义,表明结果稳健性。有限的数据表明,INO对通气时间、无呼吸机天数以及在重症监护病房和医院的住院时间没有影响。我们发现在前24小时内氧合有统计学意义但短暂的改善,以PO2与吸入氧的比例表示(平均差(MD) 15.91, 95% CI 8.25至23.56)。然而,INO似乎显著增加了成人肾脏损害的风险(RR 1.59, 95% CI 1.17 - 2.16),但对出血、高血红蛋白或二氧化氮形成的风险没有显著影响。3)我们只发现了一个小的低风险偏倚的儿科试验,研究了雾化前列环素在ALI或ARDS中的作用。基于这些有限的数据,我们无法支持或反驳ALI或ARDS常规使用这种干预措施。4)与标准治疗相比,TEG或ROTEM对总死亡率没有统计学意义(RR 0.77, 95% CI 0.35 ~ 1.72),但只有5项试验提供了死亡率的数据。我们的分析显示TEG或ROTEM对出血量有统计学意义上的影响(MD为-85.05 ml, 95% CI为-140.68至-29.42),但对其他预定结局没有统计学意义上的影响。然而,这种减少是否对患者的临床状况有影响仍不确定。结论:根据现有的证据,我们没有找到可靠的证据来支持评估的免疫凝固干预措施在重症监护中的临床应用。大部分试验存在严重的方法学缺陷,患者数量少,试验持续时间短。
{"title":"Evidence based evaluation of immuno-coagulatory interventions in critical care.","authors":"Arash Afshari","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Unlabelled: &lt;/strong&gt;Cochrane systematic reviews with meta-analyses of randomised trials provide guidance for clinical practice and health-care decision-making. In case of disagreements between research evidence and clinical practice, high quality systematic reviews can facilitate implementation or deimplementation of medical interventions into clinical practice. This applies especially to treatment of critically ill patients where interventions are most often costly and the clinical conditions are associated with high mortality.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;To assess the potential benefits or harms of 1) antithrombin III (AT III) for critically ill patients; 2) inhaled nitric oxide (INO) for acute respiratory distress syndrome (ARDS) and acute lung injury (ALI); 3) aerosolized prostacyclin for ARDS and ALI; 4) thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We performed four systematic reviews of relevant randomised clinical trials. To quantify the estimated effect of various interventions, we conducted meta-analyses, where appropriate, to determine intervention effects using the Cochrane Collaboration methodology, trial sequential analyses (TSA), the GRADE, and the PRISMA-guidelines when conducting our systematic reviews. All reviews were performed according to published protocols following the recommendations of the Cochrane Handbook for systematic reviews of interventions. We performed multiple subgroup and sensitivity analyses with regard to methodological quality and various clinical outcomes. Trials were identified through Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE Science Citation Index-Expanded, The Chinese Biomedical Database and LILACS. We included all randomized clinical trials. We hand-searched reference lists, reviews, and contacted authors and experts for additional trials. We searched ClinicalTrials.gov, Centre Watch Clinical Trials Listing Service and ControlledTrials.com for missed, unreported, or ongoing trials. We screened bibliographies of relevant articles and conference proceedings and wrote to trialists and pharmaceutical companies producing the drugs in question.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Four systematic reviews included a total of 44 trials with 5,551 patients. Only 15 of the trials were classified as trials with low risk of bias (high methodological quality) regarding generation of the allocation sequence, allocation concealment, blinding, follow-up and other types of bias. 1) Compared with placebo or no intervention, AT III did not significantly affect overall mortality (relative risk (RR) 0.96, 95% confidence interval (CI) 0.89 to 1.03). No subgroup analyses on risk of bias, populations of patients, or with and without adjuvant heparin yielded significant results. AT III significantly increased the risk of bleeding events (RR 1.52, 95% CI 1.30 to 1","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 9","pages":"B4316"},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29975354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of preoperative bowel preparation in elective colorectal surgery in Denmark remains high. 在丹麦,择期结肠手术术前肠准备的使用率仍然很高。
Pub Date : 2011-09-01
Julie Andersen, Jens Thorup, Peer Wille-Jørgensen

Introduction: Previous studies have shown that preoperative bowel preparation does not influence the frequency of postoperative complications after elective open colonic resections. The Danish Colorectal Cancer Group (DCCG) recommends that mechanical bowel preparation (MBP) should be omitted prior to elective colonic resections. Several surveys show that most surgeons use MBP before colorectal surgery. The aim of this survey was to investigate the use of preoperative bowel preparation in elective colonic and rectal resections in Denmark.

Material and methods: The survey was conducted in 2009. A questionnaire on the use of preoperative bowel preparation in elective colonic and rectal resections performed in 2008 was sent to all the departments of surgery that perform colorectal surgery in Denmark.

Results: 34% of the patients received bowel preparation before open colonic resection compared with 81% before open rectal resection. Overall, the frequency of bowel preparation was significantly higher in laparoscopic (63%) than in open surgery (50%).

Conclusion: MBP before elective open colonic resections remains widely used despite the national DCCG guideline. MBP before laparoscopic colorectal resections was more frequently used than before open colorectal resections as MBP before rectal resections was more frequently used than before colonic resections. The need for preoperative bowel preparation in these procedures has yet to be determined.

Funding: not relevant.

Trial registration: not relevant.

既往研究表明术前肠道准备不会影响择期开放式结肠切除术后并发症的发生频率。丹麦结直肠癌组(DCCG)建议在择期结肠切除术前应避免机械肠准备(MBP)。几项调查显示,大多数外科医生在结直肠手术前使用MBP。本调查的目的是调查术前肠准备在丹麦选择性结肠和直肠切除术中的应用。材料与方法:本调查于2009年进行。一份关于2008年择期结肠和直肠切除术术前肠道准备使用情况的调查问卷被发送到丹麦所有进行结肠直肠手术的外科部门。结果:34%的患者在开腹结肠切除术前接受了肠道准备,而在开腹直肠切除术前这一比例为81%。总的来说,腹腔镜下肠准备的频率(63%)明显高于开放手术(50%)。结论:尽管有国家DCCG指南,但选择性开放结肠切除术前的MBP仍被广泛使用。腹腔镜结肠切除术前MBP比开放式结肠切除术前使用频率更高,因为直肠切除术前MBP比结肠切除术前使用频率更高。在这些手术中是否需要术前肠道准备还有待确定。资金:不相关。试验注册:不相关。
{"title":"Use of preoperative bowel preparation in elective colorectal surgery in Denmark remains high.","authors":"Julie Andersen,&nbsp;Jens Thorup,&nbsp;Peer Wille-Jørgensen","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Previous studies have shown that preoperative bowel preparation does not influence the frequency of postoperative complications after elective open colonic resections. The Danish Colorectal Cancer Group (DCCG) recommends that mechanical bowel preparation (MBP) should be omitted prior to elective colonic resections. Several surveys show that most surgeons use MBP before colorectal surgery. The aim of this survey was to investigate the use of preoperative bowel preparation in elective colonic and rectal resections in Denmark.</p><p><strong>Material and methods: </strong>The survey was conducted in 2009. A questionnaire on the use of preoperative bowel preparation in elective colonic and rectal resections performed in 2008 was sent to all the departments of surgery that perform colorectal surgery in Denmark.</p><p><strong>Results: </strong>34% of the patients received bowel preparation before open colonic resection compared with 81% before open rectal resection. Overall, the frequency of bowel preparation was significantly higher in laparoscopic (63%) than in open surgery (50%).</p><p><strong>Conclusion: </strong>MBP before elective open colonic resections remains widely used despite the national DCCG guideline. MBP before laparoscopic colorectal resections was more frequently used than before open colorectal resections as MBP before rectal resections was more frequently used than before colonic resections. The need for preoperative bowel preparation in these procedures has yet to be determined.</p><p><strong>Funding: </strong>not relevant.</p><p><strong>Trial registration: </strong>not relevant.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 9","pages":"A4313"},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29975353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gender bias in specialty preferences among Danish medical students: a cross-sectional study. 丹麦医科学生专业偏好中的性别偏见:一项横断面研究。
Pub Date : 2011-09-01
Laura Toftegaard Pedersen, Nanna Hasle Bak, Agnete Skovlund Dissing, Birgit H Petersson

Introduction: Female medical students tend to prefer person-oriented specialties characterized by close doctor-patient contact and aspects of care. Conversely, male medical students tend to seek towards specialties with elements of autonomy, technology and "action" . Furthermore, female doctors will outnumber male doctors in Denmark by 2017 and this may have implications for the availability of specialized doctors.

Material and methods: Data derives from a baseline questionnaire pertaining to a Danish follow-up study. A total of 561 first year medical students enrolled in 2006 and 2007 answered the questionnaire. Binary logistic regression analysis was used to calculate odds ratio estimates of the relationship between gender and specialty preference. Variables measuring self-image were included in the analysis as potential mediators.

Results: 47% female and 19% male students pursued personoriented specialties and 46% female and 68% male students pursued technique-oriented specialties. More female students pursued technique-oriented specialties than in 1992. Female students have 69% less probability of choosing a technique-oriented specialty than males. This association is mediated by lack of self-confidence.

Conclusion: If specialty preferences are persistent during medical school, the results suggest that we will face more difficulties recruiting males to person-oriented specialties than females to technique-oriented specialties in the future. Furthermore, when addressing students' specialty preferences, we should consider both self confidence and gender.

Funding: not relevant.

Trial registration: not relevant.

导读:女医学生倾向于以人为本的专业,其特点是医患接触密切,护理方面。相反,男医学生倾向于寻求具有自主性、技术和“行动”元素的专业。此外,到2017年,丹麦女医生的数量将超过男医生,这可能会对专业医生的可用性产生影响。材料和方法:数据来源于丹麦随访研究的基线问卷。共有561名2006年和2007年入学的一年级医学生回答了问卷。采用二元logistic回归分析计算性别与专业偏好关系的比值比。测量自我形象的变量被纳入分析作为潜在的中介。结果:47%的女生和19%的男生选择了个人导向型专业,46%的女生和68%的男生选择了技术导向型专业。与1992年相比,更多的女学生选择了技术型专业。女生选择技术型专业的概率比男生低69%。这种联系是由缺乏自信介导的。结论:如果医学院的专业偏好持续下去,结果表明,未来我们将在以人为本的专业招聘男性比在以技术为本的专业招聘女性面临更多的困难。此外,在解决学生的专业偏好时,我们应该同时考虑自信和性别。资金:不相关。试验注册:不相关。
{"title":"Gender bias in specialty preferences among Danish medical students: a cross-sectional study.","authors":"Laura Toftegaard Pedersen,&nbsp;Nanna Hasle Bak,&nbsp;Agnete Skovlund Dissing,&nbsp;Birgit H Petersson","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Female medical students tend to prefer person-oriented specialties characterized by close doctor-patient contact and aspects of care. Conversely, male medical students tend to seek towards specialties with elements of autonomy, technology and \"action\" . Furthermore, female doctors will outnumber male doctors in Denmark by 2017 and this may have implications for the availability of specialized doctors.</p><p><strong>Material and methods: </strong>Data derives from a baseline questionnaire pertaining to a Danish follow-up study. A total of 561 first year medical students enrolled in 2006 and 2007 answered the questionnaire. Binary logistic regression analysis was used to calculate odds ratio estimates of the relationship between gender and specialty preference. Variables measuring self-image were included in the analysis as potential mediators.</p><p><strong>Results: </strong>47% female and 19% male students pursued personoriented specialties and 46% female and 68% male students pursued technique-oriented specialties. More female students pursued technique-oriented specialties than in 1992. Female students have 69% less probability of choosing a technique-oriented specialty than males. This association is mediated by lack of self-confidence.</p><p><strong>Conclusion: </strong>If specialty preferences are persistent during medical school, the results suggest that we will face more difficulties recruiting males to person-oriented specialties than females to technique-oriented specialties in the future. Furthermore, when addressing students' specialty preferences, we should consider both self confidence and gender.</p><p><strong>Funding: </strong>not relevant.</p><p><strong>Trial registration: </strong>not relevant.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 9","pages":"A4304"},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29975349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors: a systematic review. 宫内暴露于5 -羟色胺再摄取抑制剂后的儿科结果:一项系统综述。
Pub Date : 2011-09-01
Jesper Fenger-Grøn, Morten Thomsen, Kristian Skytte Andersen, Rasmus Gaardskær Nielsen

The use of serotonine reuptake inhibitors (SRIs) is increasing among Danish pregnant women. This systematic review addresses the potential adverse effects on the foetus and child of maternal SRI medication. The literature indicates a slightly increased risk of cardiovascular malformations and persistent pulmonary hypertension of the new-born, while evidence regarding the risk of preterm labour, low birth weight, low Apgar score, prolonged QT interval and miscarriage is less clear. An estimated 20-30% of infants will have neonatal symptoms following intrauterine SRI exposure. The symptoms may be caused by SRI withdrawal, toxicity or their overlap, but symptom aetiology basically remains controversial. The infants may exhibit neurological, gastrointestinal, autonomic, endocrine or respiratory symptoms. Although the symptoms are self-limited, the families may be seriously affected. In general, studies do not address this important aspect. Evidence concerning long-term effects is surprisingly sparse and many studies have important methodological limitations. However, present evidence does not convincingly indicate detrimental long-term effects. Until sufficient safety studies have been carried out, SRI must be used with caution in pregnancy and every treatment of the pregnant woman should be thoroughly considered.

在丹麦孕妇中,血清素再摄取抑制剂(SRIs)的使用正在增加。本系统综述探讨了母体SRI药物对胎儿和儿童的潜在不良影响。文献表明,新生儿心血管畸形和持续性肺动脉高压的风险略有增加,而关于早产、低出生体重、低Apgar评分、QT间期延长和流产的风险的证据则不太清楚。估计有20-30%的婴儿在宫内接触SRI后会出现新生儿症状。这些症状可能是由SRI戒断、毒性或它们的重叠引起的,但症状的病因基本上仍然存在争议。婴儿可能表现出神经、胃肠、自主神经、内分泌或呼吸系统症状。虽然症状是自限性的,但家庭可能会受到严重影响。一般来说,研究没有涉及到这一重要方面。关于长期影响的证据出奇地少,而且许多研究都有重要的方法学局限性。然而,目前的证据并不能令人信服地表明有害的长期影响。在进行充分的安全性研究之前,在怀孕期间必须谨慎使用SRI,并且应该彻底考虑孕妇的每一种治疗方法。
{"title":"Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors: a systematic review.","authors":"Jesper Fenger-Grøn,&nbsp;Morten Thomsen,&nbsp;Kristian Skytte Andersen,&nbsp;Rasmus Gaardskær Nielsen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The use of serotonine reuptake inhibitors (SRIs) is increasing among Danish pregnant women. This systematic review addresses the potential adverse effects on the foetus and child of maternal SRI medication. The literature indicates a slightly increased risk of cardiovascular malformations and persistent pulmonary hypertension of the new-born, while evidence regarding the risk of preterm labour, low birth weight, low Apgar score, prolonged QT interval and miscarriage is less clear. An estimated 20-30% of infants will have neonatal symptoms following intrauterine SRI exposure. The symptoms may be caused by SRI withdrawal, toxicity or their overlap, but symptom aetiology basically remains controversial. The infants may exhibit neurological, gastrointestinal, autonomic, endocrine or respiratory symptoms. Although the symptoms are self-limited, the families may be seriously affected. In general, studies do not address this important aspect. Evidence concerning long-term effects is surprisingly sparse and many studies have important methodological limitations. However, present evidence does not convincingly indicate detrimental long-term effects. Until sufficient safety studies have been carried out, SRI must be used with caution in pregnancy and every treatment of the pregnant woman should be thoroughly considered.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 9","pages":"A4303"},"PeriodicalIF":0.0,"publicationDate":"2011-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29975348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
On the use of abciximab in percutaneous coronary intervention. 阿昔单抗在经皮冠状动脉介入治疗中的应用。
Pub Date : 2011-08-01
Allan Zeeberg Iversen
{"title":"On the use of abciximab in percutaneous coronary intervention.","authors":"Allan Zeeberg Iversen","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 8","pages":"B4312"},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29920670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Danish longitudinal study of alcoholism 1978-2008. A clinical high-risk study. 1978-2008年丹麦酒精中毒纵向研究。临床高风险研究。
Pub Date : 2011-08-01
Joachim Knop
{"title":"The Danish longitudinal study of alcoholism 1978-2008. A clinical high-risk study.","authors":"Joachim Knop","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 8","pages":"B4315"},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29920672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug-related death in Denmark in 2007. 2007年丹麦与毒品有关的死亡。
Pub Date : 2011-08-01
Kirsten Wiese Simonsen, A Carsten Hansen, Dorte Rollmann, Birgitte Kringsholm, Irene Breum Müller, Sys Stybe Johansen, Kristian Linnet

Introduction: We investigated fatal poisonings among drug addicts in 2007. The cause of death, abuse pattern and geographic differences are presented.

Material and methods: All drug-related deaths examined at the three forensic medicine institutes in Denmark in 2007 were evaluated.

Results: The number of drug-related deaths in 2007 was 226. Methadone deaths had increased since 1997 while heroin/morphine deaths decreased. In earlier studies, very few deaths from central stimulants like cocaine and amphetamines occurred (1-1.5%), but in 2007 6% of the deaths were caused by these drugs. Multiple drug use was common. Heroin/morphine, cocaine, amphetamine, cannabis, methadone, benzodiazepines and alcohol were included in the poly-drug use.

Conclusion: This investigation shows stabilization in the number of fatal poisonings in drug addicts. Geographic differences were observed. Methadone was the most frequent cause of fatal poisoning and there was a continuous decrease in heroin/morphine deaths. Fatal deaths from cocaine and amphetamine have increased considerably. Multiple drug use was common.

Funding: not relevant.

Trial registration: not relevant.

我们在2007年调查了吸毒成瘾者的致命中毒。提出了死亡原因、虐待模式和地域差异。材料和方法:对2007年在丹麦三个法医研究所检查的所有与毒品有关的死亡进行了评估。结果:2007年与毒品有关的死亡人数为226人。自1997年以来,美沙酮死亡人数有所增加,而海洛因/吗啡死亡人数有所减少。在早期的研究中,很少发生可卡因和安非他明等中枢兴奋剂导致的死亡(1-1.5%),但在2007年,6%的死亡是由这些药物引起的。多种药物使用很常见。海洛因/吗啡、可卡因、安非他明、大麻、美沙酮、苯二氮卓类药物和酒精都包括在多种药物使用中。结论:本调查显示吸毒成瘾者致命中毒的数量趋于稳定。观察到地理差异。美沙酮是最常见的致命中毒原因,海洛因/吗啡致死人数持续下降。因可卡因和安非他明致死的人数大幅增加。多种药物使用很常见。资金:不相关。试验注册:不相关。
{"title":"Drug-related death in Denmark in 2007.","authors":"Kirsten Wiese Simonsen,&nbsp;A Carsten Hansen,&nbsp;Dorte Rollmann,&nbsp;Birgitte Kringsholm,&nbsp;Irene Breum Müller,&nbsp;Sys Stybe Johansen,&nbsp;Kristian Linnet","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>We investigated fatal poisonings among drug addicts in 2007. The cause of death, abuse pattern and geographic differences are presented.</p><p><strong>Material and methods: </strong>All drug-related deaths examined at the three forensic medicine institutes in Denmark in 2007 were evaluated.</p><p><strong>Results: </strong>The number of drug-related deaths in 2007 was 226. Methadone deaths had increased since 1997 while heroin/morphine deaths decreased. In earlier studies, very few deaths from central stimulants like cocaine and amphetamines occurred (1-1.5%), but in 2007 6% of the deaths were caused by these drugs. Multiple drug use was common. Heroin/morphine, cocaine, amphetamine, cannabis, methadone, benzodiazepines and alcohol were included in the poly-drug use.</p><p><strong>Conclusion: </strong>This investigation shows stabilization in the number of fatal poisonings in drug addicts. Geographic differences were observed. Methadone was the most frequent cause of fatal poisoning and there was a continuous decrease in heroin/morphine deaths. Fatal deaths from cocaine and amphetamine have increased considerably. Multiple drug use was common.</p><p><strong>Funding: </strong>not relevant.</p><p><strong>Trial registration: </strong>not relevant.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 8","pages":"A4307"},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29920668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A medical admission unit reduces duration of hospital stay and number of readmissions. 医疗住院单位减少了住院时间和再入院人数。
Pub Date : 2011-08-01
Jan C Vork, Mikkel Brabrand, Lars Folkestad, Kristian Korsgaard Thomsen, Torben Knudsen, Christian Christiansen

Introduction: Political initiatives promoting a more efficient emergency admission process have triggered a reorganisation of the Danish health system with a view to creating fewer and larger admission units counting more experienced physicians. At our hospital, a medical admission unit (MAU) was established. We present the effect of this on the length of hospital stay, mortality rates and the number of readmissions for the last year with the previous structure and the first year of the new MAU structure.

Material and methods: We retrospectively extracted data from the hospital databases on two periods: one year before and the first year after establishment of the MAU.

Results: After establishment of the MAU, the overall average length of hospital stay was reduced from 4.1 to 3.8 days (p < 0.01). No increase in mortality either in-house or within 30 days after discharge was seen. A substantial reduction (26%) in the overall number of readmissions within 30 days after discharge was observed.

Conclusion: The establishment of the MAU improved efficacy at the hospital owing to reduction in the length of hospital stay and the number of readmissions. As judged from mortality rates and indicated by readmission rates, neither the quality of treatment nor patient safety was compromised in a setup, where patients with suspected cardiac diseases are admitted along with patients suspected to suffer from other internal medical diseases. The dynamics between multidisciplinary physicians and nurses seems to improve when they are working close to each other in a setting where team spirit evolves.

Funding: not relevant.

Trial registration: not relevant.

导读:促进更有效的急诊入院过程的政治举措引发了丹麦卫生系统的重组,目的是创建更少和更大的入院单位,有更多经验丰富的医生。在我们医院,设立了一个住院病房。我们介绍了这对住院时间、死亡率和再入院人数的影响,在前一年的结构和新MAU结构的第一年。材料和方法:我们回顾性地从医院数据库中提取了两个时期的数据:建立MAU前一年和建立MAU后第一年。结果:MAU建立后,患者总平均住院时间由4.1天缩短至3.8天(p < 0.01)。住院期间或出院后30天内的死亡率均未见增加。观察到出院后30天内再入院总人数大幅减少(26%)。结论:MAU的建立减少了住院时间和再入院次数,提高了医院的疗效。从死亡率和再入院率来看,在怀疑患有心脏病的患者与怀疑患有其他内科疾病的患者一起入院的情况下,治疗质量和患者安全都没有受到损害。当多学科医生和护士在团队精神发展的环境中彼此密切合作时,他们之间的动态似乎得到了改善。资金:不相关。试验注册:不相关。
{"title":"A medical admission unit reduces duration of hospital stay and number of readmissions.","authors":"Jan C Vork,&nbsp;Mikkel Brabrand,&nbsp;Lars Folkestad,&nbsp;Kristian Korsgaard Thomsen,&nbsp;Torben Knudsen,&nbsp;Christian Christiansen","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Political initiatives promoting a more efficient emergency admission process have triggered a reorganisation of the Danish health system with a view to creating fewer and larger admission units counting more experienced physicians. At our hospital, a medical admission unit (MAU) was established. We present the effect of this on the length of hospital stay, mortality rates and the number of readmissions for the last year with the previous structure and the first year of the new MAU structure.</p><p><strong>Material and methods: </strong>We retrospectively extracted data from the hospital databases on two periods: one year before and the first year after establishment of the MAU.</p><p><strong>Results: </strong>After establishment of the MAU, the overall average length of hospital stay was reduced from 4.1 to 3.8 days (p < 0.01). No increase in mortality either in-house or within 30 days after discharge was seen. A substantial reduction (26%) in the overall number of readmissions within 30 days after discharge was observed.</p><p><strong>Conclusion: </strong>The establishment of the MAU improved efficacy at the hospital owing to reduction in the length of hospital stay and the number of readmissions. As judged from mortality rates and indicated by readmission rates, neither the quality of treatment nor patient safety was compromised in a setup, where patients with suspected cardiac diseases are admitted along with patients suspected to suffer from other internal medical diseases. The dynamics between multidisciplinary physicians and nurses seems to improve when they are working close to each other in a setting where team spirit evolves.</p><p><strong>Funding: </strong>not relevant.</p><p><strong>Trial registration: </strong>not relevant.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 8","pages":"A4298"},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30065525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular morbidity and mortality in diabetes mellitus: prediction and prognosis. 糖尿病的心血管发病率和死亡率:预测和预后。
Pub Date : 2011-08-01
Anne Sofie Astrup
{"title":"Cardiovascular morbidity and mortality in diabetes mellitus: prediction and prognosis.","authors":"Anne Sofie Astrup","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 8","pages":"B4152"},"PeriodicalIF":0.0,"publicationDate":"2011-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29920669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Danish medical bulletin
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1